Clinical Trial Update: HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update for HMPL-004 maintenance treatment in mild to moderate ulcerative colitis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• HMPL-004

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Ulcerative Colitis | Phase 3 | Status: TERMINATED | Results posted: 2020-01-13